Arthritis drugs could save lives of COVID-19 patients, study finds
January 8, 2021Medical Communications COVID-19
Two drugs used to treat rheumatoid arthritis could cut COVID-19 hospital stays by as much as 10 days, and save …
NICE recommends AstraZeneca’s FORXIGA for heart failure
January 7, 2021AstraZeneca, NICE
NICE has issued a positive Final Appraisal Document (FAD) recommending AstraZeneca’s FORXIGA (dapagliflozin) as an option for treatment of symptomatic …
New COVID-19 screening hub to be established in Scotland
January 7, 2021COVID-19
A new COVID-19 drug screening and resistance hub, funded by medical research charity LifeArc and the Medical Research Council, is …
Bolivia registers Russia’s Sputnik V COVID-19 vaccine
January 7, 2021COVID-19, Vaccine
Bolivia’s state agency for medicines and health technologies (AGEMED) has registered Russia’s Sputnik V COVID-19 vaccine under emergency use authorisation. …
Fujifilm to invest $2bn in new US cell culture production site
January 7, 2021Fujifilm Diosynth Biotechnologies
Fujifilm has announced it is investing $2 billion to establish a new large-scale cell culture production site in the US. …
EU approves Moderna’s COVID-19 vaccine
January 7, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Moderna, Vaccine
The European Commission has granted a Condition Marketing Authorisation (CMA) for Moderna’s COVID-19 vaccine, meaning the jab will soon be …
Pharmafile.com’s weekly COVID-19 news round-up
January 6, 2021Research and Development COVID-19, Vaccine
In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
WHO recommends against 12-week delay for COVID-19 vaccine doses
January 6, 2021Research and Development COVID-19, Vaccine, WHO
The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
Biogen’s IM Plegridy gets EU approval
January 6, 2021Research and Development Biogen, multiple sclerosis
The European Commission has approved Biogen’s Plegridy (peginterferon beta-1a), a new intramuscular (IM) injection for the treatment of relapsing-remitting multiple …
Angelini Pharma to acquire Arvelle Therapeutics in $960 million deal
January 6, 2021Research and Development Angelini Pharma, central nervous system
Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …
AstraZeneca’s Farxiga granted Priority Review by FDA
January 6, 2021Research and Development AstraZeneca, FDA, farxiga
AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …
Clinigen appoints Sam Herbert as Chief Operating Officer
January 5, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
PureTech appoints George Farmer as Chief Financial Officer
January 5, 2021Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
Sosei Heptares to regain rights to muscarinic agonist programmes
January 5, 2021Manufacturing and Production Sosei Heptares
Biopharmaceutical group Sosei Heptares has announced it is to regain the worldwide rights to its muscarinic agonist programmes, after they …
Israel authorises Moderna’s COVID-19 vaccine for use
January 5, 2021Manufacturing and Production COVID-19, Moderna, Vaccine
Moderna has announced that Israel’s Ministry of Health (MOH) has authorised the use of its COVID-19 vaccine. Israel has secured …
Genentech’s cancer drug gets Breakthrough Therapy Designation from FDA
January 5, 2021Manufacturing and Production Cancer, Genentech
Genentech has announced that tiragolumab, a novel cancer immunotherapy designed to bind to T cell immunoreceptor with Ig and ITIM …
Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine
January 5, 2021Manufacturing and Production COVID-19, Vaccine
Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …
Scientists develop new drug to target KRAS mutations in cancer
January 5, 2021Manufacturing and Production Cancer, Cancer Research UK
In a study funded by Cancer Research UK and Wellcome, scientists have developed a new drug that effectively targets the …
EU states to receive 100m extra doses of Pfizer-BioNTech vaccine
January 4, 2021Sales and Marketing COVID-19, EU, Pfizer, Vaccine
Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …
Concern as India approves COVID-19 vaccine before trial completion
January 4, 2021Sales and Marketing COVID-19, Vaccine
Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
